Effet du jeun de ramadan chez les femmes diabétiques ménopausées sous thérapie aux sulfamides

dc.contributor.authorCHAALA, CHERIFA
dc.date.accessioned2020-12-09T08:26:03Z
dc.date.available2020-12-09T08:26:03Z
dc.date.issued2020-09-07
dc.description.abstractRamadan represents the sacred month of the year when muslims are supposed to refrain from eating ; drinkin and having sex from sunrise to sunset. This month provides an excellent research model for studing changes in eating habits and their consequences on changes on weight status as well as fasting metabolism in people with type 2 diabetes. Twenty (20) diabetic women ; aged 54 to over 70 years ; on oral anti-diabetic with sulfamide were included in the study. Measurements and controls were carried out in the patients out 75 days before ramadan and the 15th day of ramadan and concerned (BMI ; glycemia ; HbA1c ; triglycerides ; cholesterol ; LDL-c ; HDL-c ; protein ; Creatinine and urea). The results underwent a single- factor block-factor variance analysis and a comparison of two-point means according to the Newman and Keuls test. Ramadan fasting appears to significantly improve glycemic control and plasma lipid (LDL ;HDL and cholesterol) balance in leadopausal diabetic women . In addition ; the experiment reveals that patients have no hypoglycemia and no renal function that prevent them from fasting.en_US
dc.identifier.urihttp://e-biblio.univ-mosta.dz/handle/123456789/16060
dc.language.isofren_US
dc.subjectype 2 diabetesen_US
dc.subjectmenopauseen_US
dc.subjectramadanen_US
dc.subjectfastingen_US
dc.subjectparametrization biochemical.en_US
dc.titleEffet du jeun de ramadan chez les femmes diabétiques ménopausées sous thérapie aux sulfamidesen_US
dc.typeOtheren_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
8 cheaala edmslvbclfd 11(Réparé) - Copie (2).pdf
Size:
2.3 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: